Stock Events

Stock Events

SB Technology 

$0.4000
12
-$0.00-0% Tuesday 19:47

Statistics

Day High
0.4
Day Low
0.4
52W High
2.25
52W Low
0.1385
Volume
1,683
Avg. Volume
-
Mkt Cap
8.44B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

19NovExpected
Q1 2014
Q3 2014
Q3 2014
Q1 2015
Q1 2015
Q2 2015
Q3 2015
-0.09
-0.06
-0.04
-0.01
Expected EPS
N/A
Actual EPS
-0.01

Financials

-Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
0Revenue
4.24MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VGLS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap155.93B
Gilead Sciences is a biopharmaceutical company that competes in the development of treatments similar to VG Life Sciences, focusing on areas such as infectious diseases.
AMGEN
AMGN
Mkt Cap191.7B
Amgen is a biotech firm that competes with VG Life Sciences in the development of innovative therapies and drugs, particularly in the areas of oncology and cardiovascular diseases.
Merck
MRK
Mkt Cap294.03B
Merck & Co. is a global healthcare company that develops pharmaceuticals across various areas, including those that overlap with VG Life Sciences' research interests.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is a pharmaceutical corporation with a broad range of products in various therapeutic areas, competing with VG Life Sciences in the development and marketing of drugs.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol-Myers Squibb is a biopharmaceutical company that develops drugs in areas like cancer, competing directly with VG Life Sciences in the oncology sector.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie operates in the pharmaceutical industry, focusing on treatments for conditions in areas such as immunology and oncology, making it a competitor to VG Life Sciences.
Novartis
NVS
Mkt Cap292.07B
Novartis is a global healthcare company that produces drugs in several therapeutic areas, including those that compete with VG Life Sciences' research and development focus.
Roche
RHHBY
Mkt Cap332.67B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with VG Life Sciences in the biotechnology and pharmaceutical sectors.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson is a diversified healthcare company that develops and sells pharmaceuticals and biopharmaceuticals, competing with VG Life Sciences across multiple therapeutic areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap64.18B
Regeneron Pharmaceuticals is a biotechnology company that develops and commercializes medicines for serious medical conditions, directly competing with VG Life Sciences in the biopharmaceutical field.

About

SB Technology Holdings, Inc. operates as a holding company and is currently undertaking a significant realignment of its business operations. The company was established by Haig Keledjian on July 11, 1995, and its main office is situated in New York, NY.
Show more...
CEO
Mr. William P. Farrand
Employees
1
Country
United States
ISIN
US91822T2006

Listings

OTCM
US
VGLSD
OTC Link
US
VGLS

0 Comments

Share your thoughts

FAQ

What is SB Technology stock price today?▼
The current price of VGLS is $0.40 USD — it has decreased by -0% in the past 24 hours. Watch SB Technology stock price performance more closely on the chart.
What is SB Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SB Technology stocks are traded under the ticker VGLS.
Is SB Technology stock price growing?▼
VGLS stock has fallen by -9.09% compared to the previous week, the month change is a -6.98% fall, over the last year SB Technology has showed a -60% decrease.
What is SB Technology market cap?▼
Today SB Technology has the market capitalization of 8.44B
What were SB Technology earnings last quarter?▼
VGLS earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SB Technology revenue for the last year?▼
SB Technology revenue for the last year amounts to 0 USD.
What is SB Technology net income for the last year?▼
VGLS net income for the last year is 4.24M USD.
How many employees does SB Technology have?▼
As of June 17, 2026, the company has 1 employees.
In which sector is SB Technology located?▼
SB Technology operates in the Health & Wellness sector.
When did SB Technology complete a stock split?▼
The last stock split for SB Technology was on April 16, 2026 with a ratio of 1:20000.
Where is SB Technology headquartered?▼
SB Technology is headquartered in New York, United States.